Open Access3 QUESTIONS ON... When Enthusiasm for New Cancer Drugs Is Premature
Author(s) -
Sarah DiGiulio
Publication year - 2021
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000743604.69892.90
Subject(s) - osimertinib , medicine , lung cancer , oncology , clinical trial , clinical endpoint , randomized controlled trial , cancer , family medicine , erlotinib , epidermal growth factor receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom